Compared with tumor-associated antigens (TAAs) expressed in both tumor and normal tissues, neoantigens exhibit stronger immunogenicity and higher affinity toward MHC (major histocompatibility complex), and are not affected by central immunological tolerance. This evidence concerns the gene HLA-C and neoplasm.